Akari Therapeutics, Plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Akari Therapeutics, Plc (AKTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 335.65 thousand shares for the 6-month period ending 2024-06-30, per its 8-K filed 2024-09-06.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-09-06
- Akari Therapeutics, Plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2015-06-30 was 200.00K shares.
- Akari Therapeutics, Plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2015-03-31 was 0.00 shares.
- Akari Therapeutics, Plc share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2014 was 145.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|
| 2024-06-30 | 335.65K shares 8-K · filed 2024-09-06 | ||
| 2023-12-31 | 52.21K shares 8-K · filed 2024-09-06 | ||
| 2022-06-30 | 16.27M shares 6-K · filed 2022-09-27 | ||
| 2020-12-31 | 2.50M shares 20-F · filed 2022-05-16 | ||
| 2019-12-31 | 7.55M shares 20-F · filed 2022-05-16 | ||
| 2018-12-31 | 37.12M shares 20-F · filed 2021-04-21 | ||
| 2017-12-31 | 40.01M shares 20-F · filed 2020-03-31 | ||
| 2016-12-31 | 4.69M shares 20-F · filed 2019-04-23 | ||
| 2015-06-30 | 200.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 200.00K shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | ||
| 2014-12-31 | 145.00K shares 10-K · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |